158 related articles for article (PubMed ID: 27832522)
1. Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.
Almeida VR; Vieira IA; Buendia M; Brunetto AT; Gregianin LJ; Brunetto AL; Klamt F; de Farias CB; Abujamra AL; Lopez PLDC; Roesler R
Mol Neurobiol; 2017 Dec; 54(10):7610-7619. PubMed ID: 27832522
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
Joshi S; Guleria R; Pan J; DiPette D; Singh US
Oncogene; 2006 Jan; 25(2):240-7. PubMed ID: 16158052
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma.
Meister B; Fink FM; Hittmair A; Marth C; Widschwendter M
Anticancer Res; 1998; 18(3A):1777-86. PubMed ID: 9673404
[TBL] [Abstract][Full Text] [Related]
4. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
Kato Y; Egusa C; Maeda T; Tsuboi R
J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2.
Alique M; Herrero JF; Lucio-Cazana FJ
J Neuroinflammation; 2007 Jan; 4():1. PubMed ID: 17204142
[TBL] [Abstract][Full Text] [Related]
6. Reversible upregulation of tropomyosin-related kinase receptor B by geranylgeranoic acid in human neuroblastoma SH-SY5Y cells.
Sakane C; Shidoji Y
J Neurooncol; 2011 Sep; 104(3):705-13. PubMed ID: 21373967
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
8. Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARbeta expression.
Hewson QC; Lovat PE; Pearson AD; Redfern CP
J Cell Biochem; 2002; 87(3):284-91. PubMed ID: 12397610
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.
Duffy DJ; Krstic A; Halasz M; Schwarzl T; Konietzny A; Iljin K; Higgins DG; Kolch W
Genome Med; 2017 Feb; 9(1):15. PubMed ID: 28187790
[TBL] [Abstract][Full Text] [Related]
10. Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells.
Marshall GM; Cheung B; Stacey KP; Camacho ML; Simpson AM; Kwan E; Smith S; Haber M; Norris MD
Oncogene; 1995 Aug; 11(3):485-91. PubMed ID: 7630632
[TBL] [Abstract][Full Text] [Related]
11. Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma.
Bayat Mokhtari R; Baluch N; Ka Hon Tsui M; Kumar S; S Homayouni T; Aitken K; Das B; Baruchel S; Yeger H
BMC Cancer; 2017 Feb; 17(1):156. PubMed ID: 28235409
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid receptors alpha and gamma mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells.
Melino G; Draoui M; Bellincampi L; Bernassola F; Bernardini S; Piacentini M; Reichert U; Cohen P
Exp Cell Res; 1997 Aug; 235(1):55-61. PubMed ID: 9281352
[TBL] [Abstract][Full Text] [Related]
13. Retinoid X receptors and retinoid response in neuroblastoma cells.
Rana B; Veal GJ; Pearson AD; Redfern CP
J Cell Biochem; 2002; 86(1):67-78. PubMed ID: 12112017
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of silenced α-N-catenin induces retinoic acid sensitivity in neuroblastoma cells.
Clark RA; Newton M; Qiao J; Lee S; Chung DH
Surgery; 2021 Nov; 170(5):1546-1553. PubMed ID: 34092372
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells.
Ohnuma-Ishikawa K; Morio T; Yamada T; Sugawara Y; Ono M; Nagasawa M; Yasuda A; Morimoto C; Ohnuma K; Dang NH; Hosoi H; Verdin E; Mizutani S
Cancer Res; 2007 Feb; 67(3):1019-29. PubMed ID: 17283134
[TBL] [Abstract][Full Text] [Related]
17. ATRA inhibits ceramide kinase transcription in a human neuroblastoma cell line, SH-SY5Y cells: the role of COUP-TFI.
Murakami M; Ito H; Hagiwara K; Yoshida K; Sobue S; Ichihara M; Takagi A; Kojima T; Tanaka K; Tamiya-Koizumi K; Kyogashima M; Suzuki M; Banno Y; Nozawa Y; Murate T
J Neurochem; 2010 Jan; 112(2):511-20. PubMed ID: 19903244
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors regulate retinoic acid receptor beta expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms.
De los Santos M; Zambrano A; Sánchez-Pacheco A; Aranda A
Mol Endocrinol; 2007 Oct; 21(10):2416-26. PubMed ID: 17622583
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid enhances sensitivity of neuroblastoma cells for imatinib mesylate.
Neumann I; Foell JL; Bremer M; Volkmer I; Korholz D; Burdach S; Staege MS
Pediatr Blood Cancer; 2010 Sep; 55(3):464-70. PubMed ID: 20658618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
